動態

• 

  Mary Grace N. Tamio  

  在 October 30 2023 at 07:34 PM 已編輯 public

  Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis
  
  #rituximab #lupusnephritis #journals #articles
  
  More info | ⬇️
  https://social.cn1699.com/livenewss/news/258714

  

  Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 June 11 2023 at 08:29 PM 已編輯 public

  Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis
  
  #lupusnephritis #machinelearning #journals #articles
  
  More info | ⬇️

  

  Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis

  Diagnosis of lupus nephritis (LN) is a complex process, which usually requires renal biopsy. We aim to establish a machine...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 July 29 2022 at 05:23 PM 已編輯 public

  Stability of novel urinary biomarkers used for lupus nephritis
  
  #urinarybiomarkers #lupusnephritis #journals #articles
  
  For more information | ⬇️

  

  Stability of novel urinary biomarkers used for lupus nephritis

  BackgroundThe Renal Activity Index for Lupus (RAIL) is a composite score of six urinary biomarkers (neutrophil gelatinase–...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享